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expression of WISP1 in synovium and cartilage. This signiﬁes
that wnt-signaling pathways are activated in preclinical species
and in human disease, and also results in upregulation of ma-
trix degrading enzymes in synovium and cartilage. We also
demonstrated that high synovial WISP1 expression can cause
enzyme-mediated cartilage damage, which may be independent
of IL-1. These results demonstrate a potential role for WISP1 in
experimental OA and in human OA clinical samples.
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DISRUPTION OF ENDOPLASMIC RETICULUM STRESS
SIGNALING IN CARTILAGE-SPECIFIC SITE-1 PROTEASE
KNOCKOUT MICE RESULTS IN ABNORMAL MATRIX AND
LACK OF ENDOCHONDRAL OSSIFICATION
D. Patra1, X. Xing1, J. Bryan1, C. Franz1, E. Hunziker2,
L.J. Sandell1
1Washington University School of Medicine, St. Louis, MO; 2ITI
Research Institute, University of Bern, Bern, Switzerland
Purpose: Site-1 protease (S1P) is a proprotein convertase that
plays an essential role in the processing of latent, membrane-
bound transcription factors such as SREBPs and ATF6, to their
free and active form. While SREBPs are involved in cholesterol
and fatty acid homeostasis, ATF6 is involved in endoplasmic
reticulum stress signaling (ERSS) also called the unfolded protein
response. The importance of S1P in cartilage development and
lipid synthesis was demonstrated in literature by the zebraﬁsh
gonzo mutant with knockdown in S1P, but the exact requirement
of S1P in cartilage development is not known. The goal of this
study was to analyze the requirement of S1P in cartilage and
bone development.
Methods: Cartilage-speciﬁc S1P knockout mice (S1Pcko) were
created by crossing S1Pf/f mice (homozygous for the S1Pﬂox
allele in which exon 2 of S1P is ﬂoxed) with S1Pf/+; Col2-Cre
mice (heterozygous for the S1Pﬂox allele and positive for the
Col2-Cre transgene in which the Cre recombinase is under the
inﬂuence of the cartilage-speciﬁc type II collagen promoter) to
generate cartilage-speciﬁc deletion of S1P activity. S1Pcko mice
and wild type littermates were studied by histology, immunohis-
tochemistry (IHC), in situ hybridization, and electron microscopy
techniques. Extraction of collagens from cartilage were done
with 4M guanidine-hydrochloride (Gu-HCl) followed by pepsin
digestion and analysis by western blotting.
Results: S1Pcko mice suffer from severe chondrodysplasia with
deformed limbs. Histological studies show a lack of endochon-
dral ossiﬁcation in S1Pcko mice even though mineralization of the
hypertrophic cartilage, expression of type X collagen and VEGF
occur normally. Ihh signaling pathway and osteoblastogenesis
pathways are intact in S1Pcko mice. However, S1Pcko mice have
an abnormal matrix. While there is no decrease in the number
of chondrocytes in the limbs, the cells are more densely packed
and randomly oriented. There is also a dramatic increase in
chondrocyte apoptosis in the cartilage of S1Pcko mice. Western
blot analysis of Gu-HCl-extracted and pepsin-digested cartilage
from S1Pcko mice shows a signiﬁcant decrease in Col2 protein
extraction from S1Pcko cartilage. IHC analysis of the distribution
of type IIA collagen and type IIB collagen shows that both type
IIA and type IIB collagen proteins are expressed. However, while
type IIA collagen is incorporated into the matrix, the incorpora-
tion of type IIB collagen into the matrix is disrupted in S1Pcko
mice. Type IIB collagen appears to be primarily trapped inside
the cell presumably in the ER. Electron microscopy of S1Pcko
cartilage shows that the ER is engorged and fragmented and the
deposition of collagen ﬁbrils into the matrix is not consistent.
Conclusions: S1P is essential to endochondral ossiﬁcation and
in the genesis of a normal cartilage matrix which is the forerunner
for endochondral bone morphogenesis. It had been thought that
ERSS was stimulated only by mutant proteins. However, in this
study the disruption of S1P resulted in ER stress like-symptoms
such as engorgement and fragmentation of ER even in the
absence of a mutant cartilage protein. As ATF6 is required for
ERSS and is a substrate for S1P, ERSS is likely to be defective
in S1Pcko chondrocytes. These results suggest that the ERSS
is a normal metabolic event in chondrocytes likely due to the
dramatic increase in secreted proteins. Thus for the ﬁrst time,
we show that chondrocytes have a unique secretory apparatus.
Understanding of this pathway should be useful in cartilage
diseases and tissue engineering.
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CARTILAGE INNATE IMMUNITY AND OA: THE SHARED
TLR AND IL-1 RECEPTOR ADAPTOR MYD88 IS CENTRAL
TO BOTH CHONDROCYTE HYPERTOPHY AND MATRIX
CATABOLISM
R.L. Bryan, C. Yoon, R. Terkeltaub
VAMC, UCSD, San Diego, CA
Purpose: Low-grade joint inﬂammation in OA cartilage promotes
altered chondrocyte differentiation and matrix catabolism, medi-
ated partly by IL-1, TNFalpha, and chemokines and the induction
of chondrocyte hypertrophy. However, chondrocytes also express
TLRs and their adaptors involved in innate immune responses.
Moreover, at least one endogenous TLR2 and TLR4 ligand (low
molecular weight hyaluronan (LMW-HA)) is increased in the joint
as OA progresses. Stimulation of chondrocytes by microbial
TLR2 and TLR4 ligands such as peptidoglycan (PGN) and LPS
induces matrix catabolic responses in vitro. Since MyD88 is a
critical and shared adaptor protein for the IL-1 receptor and TLRs,
we probed the roles of TLR2, TLR4 and MyD88 in chondrocyte
differentiation and function pertinent to phenotypic changes that
develop in OA.
Methods: We studied immature primary mouse knee articu-
lar chondrocytes and femoral head cap cartilage explants from
two months old MyD88 knockout (KO), TLR2/4 double KO and
congenic wild type mice. Stimuli given were cytokines, PGN,
puriﬁed LPS (pLPS) or LMW-HA for up to 3 days. GAG re-
lease, nitric oxide (NO) generation, MMP-3, MMP-13, ADAMts5
and the chondrocyte hypertrophy marker Type X collagen ex-
pression were analyzed by the dimethyl methylene blue (DMB)
colorimetric assay, the Greiss reaction, and Western blotting, re-
spectively. In addition, we examined Type X collagen expression
in bovine knee articular chondrocytes transfected with dominant
negative MyD88 or with Tollip (the ubiquitin-binding protein that
suppresses both IL-1R and TLR signal transduction).
Results: First, IL-1β, PGN and pLPS induced GAG and NO
release, MMP-3, MMP-13 and ADAMts5 expression in wild type
but not MyD88 KO mouse femoral head cap explants culture
or knee chondrocytes in control studies. Second, MyD88 KO
suppressed chondrocyte activation by TNFalpha (which is nei-
ther a TLR or IL-1 receptor agonist) in mouse cartilage explants
and chondrocytes. Speciﬁcally, MyD88 KO caused a >70% drop
in GAG and NO release (p<0.05), and it decreased MMP-3,
MMP-13 and ADAMTS-5 expression in response to TNFalpha.
Third, MyD88 KO attenuated TNFalpha-induced Type X collagen
expression in mouse chondrocytes. Fourth, dominant negative
MyD88 and Tollip transfection attenuated Type X collagen expres-
sion in normal bovine knee articular chondrocytes in response to
cytokines TNFalpha and CXCL8. Last, LMW-HA induced MMP-3
and MMP-13 expression in wild type, but LMW-HA failed to do
so in either MyD88 KO or TLR2/4 double KO mouse cartilage
explants and knee chondrocytes.
Conclusions: MyD88 is central for mediating chondrocyte dif-
ferentiation and catabolic responses not only to IL-1β but also to
TNFα and CXCL8 and to the endogenous TLR2 and TLR4 ligand
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LMW-HA. Therefore, chondrocyte MyD88 expression is critical
for coupling inﬂammation and innate immunity with the potential
progression of OA. Chondrocyte MyD88 function represents a
novel potential therapeutic target in OA.
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BONE MARROW LESIONS FROM OSTEOARTHRITIS
KNEES ARE CHARACTERIZED BY SCLEROTIC BONE
THAT IS LESS WELL MINERALIZED
D.J. Hunter1, E. Morgan2, L. Gerstenfeld2, G. Bishop2,
P. McCree1, T. Einhorn2, R.A. Maciewicz3, P. Newham3
1New England Baptist Hospital, Boston, MA; 2Boston University,
Boston, MA; 3AstraZeneca, Macclesﬁeld, United Kingdom
Purpose: Although the presence of bone marrow lesions (BML)
on MRI is strongly associated with osteoarthritis (OA) progres-
sion and pain, the underlying pathology is not well established.
The lack of knowledge on what contributes to these lesions ham-
pers their clinical utility. The aim of this study was to evaluate
the architecture of subchondral bone in regions with and without
BMLs from the same individual using bone histomorphometry.
Methods: Postmenopausal female subjects with predominantly
medial compartment OA, on a waiting list for total knee replace-
ment (TKR) were recruited. To identify the location of the BMLs,
subjects had an MRI performed on their study knee prior to TKR
using a Philips 3.0T scanner with a dedicated extremity coil. The
following imaging sequence was used on each patient: Sagittal
dual echo FSE fat suppressed/WEwith TR/Te of ∼4000ms/15ms,
60ms, 2.5- 3mm slices, no skip/gap, 256x256 matrix, 12cm FOV
(for distal femur and proximal tibia). An axial map of the tibial
plateau was made delineating the precise location of the BML.
After surgical removal of the tibial plateau, the BML was localized
using the axial map from the MR image and the lesion excised
along with a comparably sized bone specimen adjacent to the
BML and from the contralateral compartment without a BML.
Cores were taken from the excised material and the mineral
density, bone volume fraction (BV/TV), and trabecular number
(Tb.N), thickness (Tb.T), and spacing (Tb.Sp) of the cortical-like
subchondral plate and the subchondral trabecular bone were
Abstract 12 – Table 1
Medial tibia Medial tibia p value comparing medial BML Lateral p value comparing medial BML
affected by BML unaffected by BML with unaffected medial plateau tibial plateau with lateral tibial plateau
BV/TV 0.27 (0.07) 0.16 (0.03) 0.01 0.16 (0.06) 0.03
Mineral density (mg HA/ccm) 1037.97 (23.31) 1089.27 (21.38) 0.007 1050.94 (18.86) 0.36
Tb.N (1/mm) 2.74 (0.38) 1.20 (0.32) 0.0001 2.56 (0.87) 0.68
Tb.Th (mm) 0.31 (0.09) 0.23 (0.02) 0.09 0.23 (0.07) 0.15
Tb.Sp (mm) 0.38 (0.13) 1.01 (0.32) 0.004 0.45 (0.23) 0.57
Medial BML. Medial tibial plateau unaffected by BML. Lateral tibial plateau unaffected by BML
assessed using micro-computed tomography imaging (Scanco
CT40). We computed the mean and SD for each parameter, and
the unaffected bone from the medial tibial plateau and the bone
from the lateral tibial plateau were compared with the affected
BML region in the medial tibial plateau.
Results: 5 participants ranging in age from 48 to 90 years of age
were recruited. The table depicts the micro-CT parameters from
the affected (medial), unaffected medial and unaffected lateral
compartments of the knee.
A representative image from the medial tibial plateau affected
by BML, medial tibial plateau unaffected by BML and the lateral
tibial plateau unaffected by BML is presented; the sub-chondral
plate is orientated at the top.
Conclusions: Our preliminary data localizes speciﬁc changes in
bone mineralization, remodeling and defects within BML features
that are adjacent to the sub-chondral plate. These BMLs appear
to be sclerotic compared to unaffected regions from the same
individual based on the increased bone volume fraction and
increased number of trabeculae. However, the mineral density in
these lesions is reduced and may render this area mechanically
compromised, and thus susceptible to attrition. Further work is
required to evaluate whether these observations are caused by
an increase in synthesis or a decrease in resorption of the bone.
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THE REMODELLING PROCESS OF THE SUBCHONDRAL
BONE DURING HUMAN OSTEOARTHRITIS IS CLOSELY
DEPENDENT ON RANKL MODULATION
S. Kwan Tat1, J-P. Pelletier1, D. Lajeunesse1, H. Fahmi1,
N. Duval2, J. Martel-Pelletier1
1Osteoarthritis Research Unit, University of Montreal Hospital
Centre, Notre-Dame Hospital, Montreal, PQ, Canada; 2Pavillon
des Charmilles, Vimont, PQ, Canada
Purpose: Osteoarthritis (OA) is the most common joint pathol-
ogy and recent studies have suggested that the subchondral
bone metabolism is intimately involved in cartilage degradation
and loss. Bone remodelling is tightly regulated by a molecular
triad composed of OPG/RANK/RANKL. RANKL enhances osteo-
